Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Cyclophosphamide uses?

See the DrugPatentWatch profile for Cyclophosphamide

Cyclophosphamide is a chemotherapy drug used to treat various cancers and as an immunosuppressant.

What cancers does cyclophosphamide treat?


Cyclophosphamide is prescribed for a range of cancers, including lymphomas (such as Hodgkin's and non-Hodgkin's lymphoma), multiple myeloma, and leukemias (like chronic lymphocytic leukemia and chronic myelogenous leukemia). It is also used to treat breast cancer, ovarian cancer, and neuroblastoma. Additionally, it is employed in the treatment of mycosis fungoides, a type of cutaneous T-cell lymphoma [1].

How does cyclophosphamide work as an immunosuppressant?


As an immunosuppressant, cyclophosphamide is used to reduce the activity of the immune system. This is beneficial in treating autoimmune diseases and in preventing organ transplant rejection. Its mechanism involves depleting the body's lymphocytes, particularly T-cells and B-cells, which are key components of the immune response [2].

What are the potential side effects of cyclophosphamide?


Cyclophosphamide can cause a variety of side effects. These may include nausea and vomiting, hair loss (alopecia), and a decrease in blood cell counts, leading to an increased risk of infection (leukopenia), bleeding (thrombocytopenia), and anemia. It can also cause bladder toxicity (hemorrhagic cystitis), infertility, and, in rare cases, secondary cancers [3].

Are there specific preparations or forms of cyclophosphamide available?


Cyclophosphamide is typically administered orally in tablet form or intravenously as an injection. The choice of administration depends on the specific medical condition being treated and the patient's overall health status [1].

What is the mechanism of action for cyclophosphamide?


Cyclophosphamide is an alkylating agent. It is a prodrug that requires activation by enzymes in the liver. Once activated, it forms compounds that bind to DNA, preventing cancer cells from replicating and dividing. This interference with DNA synthesis ultimately leads to cell death [4].

What regulatory bodies oversee cyclophosphamide?


Like other prescription medications, cyclophosphamide is regulated by health authorities such as the U.S. Food and Drug Administration (FDA) to ensure its safety and efficacy for approved uses [1].

Where can I find information on drug patents related to cyclophosphamide?


Information regarding patents for drugs like cyclophosphamide, including their expiry dates and any related patent litigation, can often be found on specialized patent tracking websites. DrugPatentWatch.com is a resource that provides data on drug patents and intellectual property [5].

Sources


1. https://www.drugpatentwatch.com/drug/cyclophosphamide
2. National Cancer Institute. Cyclophosphamide (PDQ®)–Health Professional Version.
3. Mayo Clinic. Cyclophosphamide (Intravenous Route, Oral Route) Side Effects.
4. U.S. National Library of Medicine. Cyclophosphamide.
5. https://www.drugpatentwatch.com/



Other Questions About Cyclophosphamide :

Who makes cyclophosphamide? Cyclophosphamide price with insurance? Inj cyclophosphamide price? Cyclophosphamide patent expiration date year only? Cost of cyclophosphamide 2024? Cyclophosphamide 600mg? Cyclophosphamide 1000 mg price?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
73
Visibility
86
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

chemotherapy drug used to treat various cancers


Core Claims
  • Cyclophosphamide is a chemotherapy drug used to treat various cancers
  • It is also used to treat as an immunosuppressant
  • It can cause side effects including nausea, hair loss, and blood cell count decreases
Differentiators
  • Used as an immunosuppressant by depleting lymphocytes, particularly T-cells and B-cells
  • Mechanism involves being an alkylating-agent prodrug activated in the liver, binding to DNA

Pricing Perception: Not Mentioned